Table 2.
Inflammation parameters in blood 6 h after bronchial segmental challenge with placebo, 10 μg, 50 μg, or 100 μg carbon nanoparticles
Peripheral Blood Cells × 109/L | Placebo (n = 9) | 10 μg NP (n = 4) | 50 μg NP (n = 4) | 100 μg NP (n = 9) | P-value |
---|---|---|---|---|---|
Leukocytes | 6.61 ± 0.38 | 6.10 ± 0.45 | 7.65 ± 1.13 | 8.24 ± 0.77 | 0.061 |
Neutrophils | 4.22 ± 0.38 | 3.87 ± 0.68 | 5.24 ± 1.12 | 5.66 ± 0.69 | 0.046 |
Lymphocytes | 1.76 ± 0.11 | 1.64 ± 0.28 | 1.78 ± 0.17 | 1.89 ± 0.11 | 0.934 |
Monocytes | 0.49 ± 0.03 | 0.48 ± 0.04 | 0.55 ± 0.08 | 0.57 ± 0.06 | 0.156 |
Eosinophils | 0.13 ± 0.03 | 0.07 ± 0.03 | 0.07 ± 0.03 | 0.10 ± 0.04 | 0.602 |
Basophils | 0.03 ± 0.01 | 0.04 ± 0.01 | 0.03 ± 0.01 | 0.02 ± 0.00 | 0.970 |
Values are expressed as mean ± SEM. The correlations between dose of nanoparticles and changes from baseline of cell numbers were non-parametrically analyzed by Spearman correlation. Abbreviations: NP nanoparticles